Navigation Links
Preventing Vision Loss

A simple vitamin supplement could significantly reduce the number of people with vision loss from age-related macular degeneration, or AMD, finds a new study.//

AMD, which is caused by a deterioration of the retina, is the number one cause of blindness among older people. A couple of years ago, researchers conducted a large study to see if a combination of the antioxidant vitamins C, E, and beta carotene, along with zinc oxide or zinc alone could slow down or prevent AMD among those considered at high risk for the advanced form of the condition. Results showed a significant effect for those taking the high dose supplements.

In this study, investigators from the Age-Related Eye Disease Research Group built on those results by estimating the impact the supplements could have on the total population of people at risk for developing advanced AMD. First, they estimated about 8 million people 55 and older have early signs of AMD and are at high risk of developing advanced disease and significant vision loss. About 1.3 million, they say, would go on to develop advanced AMD without preventative treatment.

The investigators’ model suggests more than 300,000 of these people could avoid advanced AMD over the next five years if they took the vitamin supplements recommended by the earlier study.

They write, "Avoiding the development of advanced AMD can have a major effect on the quality of life for an individual ... These data suggest that the recommendations of such a supplement for those individuals should have a major impact on them as well as on the public health.
'"/>




Page: 1

Related medicine news :

1. Preventing mental decline in the aged
2. Preventing white coat hypertension
3. Preventing Childhood Deaths
4. Preventing Vision Loss
5. Preventing Colorectal Cancer
6. Preventing Prostate Cancer
7. Lycopene Can Help In Preventing Prostate Cancer
8. Heart Drug Also Effective In Preventing Specific Causes Of Death
9. Preventing cavities in children
10. Preventing Strokes Using Less Invasive Techniques
11. Preventing Bone Metastasis In Patients With Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/8/2016)... ... December 08, 2016 , ... David J. Dykeman , Ginger ... Traurig, LLP, will speak at DeviceTalks West, Dec. 12, 2016, at the Fairmont Newport ... attorneys from the firm’s global Life Sciences & Medical Technology Group have been featured ...
(Date:12/8/2016)... ... 2016 , ... STATEN ISLAND, N.Y., Nov. 24, 2016 — ... highest standards of trauma, maternity, cancer and chronic obstructive pulmonary disease (COPD) services ... Daniel Messina. , Among the recognitions, the American College of Surgeons' (ACS) named ...
(Date:12/8/2016)... ... ... Vida Health, the digital health platform that pairs individuals with ... . Other investors include Nokia Growth Partners (NGP) and returning investor Aspect Ventures. Vida ... are managing chronic conditions or simply want to improve their health. Canvas ...
(Date:12/8/2016)... ... , ... Coppin Insurance Agency, an insurance and financial planning firm based in ... area, is embarking on a charity drive with the goal of providing support and ... Food Bank of Southwest Florida works to provide fresh and nutritious food free of ...
(Date:12/7/2016)... Washington,DC (PRWEB) , ... December 07, 2016 , ... ... Forum (NYLF): Medicine will have the unique opportunity to get hands-on experience ... gives high school students an immersive experience to gain invaluable, real-life medical skills ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... 2016  Pennsylvania Physician General Dr. Rachel ... Programs Gary Tennis released safe prescribing ... benzodiazepines, developed with the help of a task ... are frequently prescribed for anxiety or insomnia," said ... opioid pain medications, benzodiazepines pose a significant risk ...
(Date:12/8/2016)... DANVILLE, Pa. , Dec. 8, 2016  A ... physicians reports that the use of opioid therapy to ... actually increase the likelihood of more harmful consequences, including ... Davis , M.D., and Zankhana Mehta , M.D., ... current research on chronic opioid therapy. The study was ...
(Date:12/8/2016)... CAMBRIDGE, Mass. , Dec. 8, 2016 /PRNewswire/ ... that it has obtained proof-of-mechanism for neflamapimod (previously ... recently completed Phase 2a clinical trials that demonstrated ... from Study 302 (12-week treatment) and Study 303 ... the Clinical Trials in Alzheimer,s Disease (CTAD) scientific ...
Breaking Medicine Technology: